Publications

The utopian vision of globally integrated, democratic, free-market economies working together in harmony has not materialized. Meanwhile, the belief that China could not innovate—and that America would continue to lead in advanced technologies—also has proven to be false. These new realities require bold reforms in the U.S. research system.

The Commission should approve this transaction because it will serve the public interest by increasing spectrum productivity, increasing competition in the emerging D2D marketplace, and extending mobile communications coverage to remote and underserved areas.

Both small and large firms are essential to America’s innovation system because they specialize in different forms of innovation. Congress should double the regular R&D tax credit to 40 percent and reduce the red tape associated with claiming it.

Joseph V. Coniglio hosts retired Jones Day partner and former DOJ Antitrust Division leader Joe Sims, who recounts how he discovered antitrust in law school, explains the origins and impact of the Hart-Scott-Rodino Act, and forecasts diminished FTC antitrust authority.

Manufacturing labor productivity growth is a key driver of the United States’ long-term economic performance and global competitiveness, but it has slowed sharply since 2005. Congress should provide a 25 percent tax credit to firms adopting productivity-enhancing technologies to help reverse this slowdown.

Canada should significantly expand commercialization-focused grant programs through the Canadian Institutes of Health Research (CIHR) and increase Canada’s overall health science research investments to a scale commensurate with global competition.

German exports to China as a share of GDP have declined by more than 40 percent since 2021, while the German labor force has seen a decline of more than 400,000 jobs linked to exports to China.

Canada funds university research but gives universities too little reason to turn that into Canadian firms, patents, and industrial capacity. To better align their incentives with national goals, funding should flow in part on standardized commercialization outcomes, with universities left to decide how to deliver them.

China has utilized numerous illegitimate tools in pursuit of global leadership in biopharmaceutical manufacturing, including IP theft, forced labor, and stealing genetic information. This must be met with a swift and forceful response from U.S. policymakers.

The United States is the global power in space, but insufficient spaceport infrastructure threatens the growth of the American space industry. Congress, NASA, and Space Force must address the problem before it undermines U.S. leadership.